Castle Biosciences (CSTL) Goodwill (2022 - 2026)

Castle Biosciences has disclosed Goodwill across 5 years of filings, most recently posting $10.7 million for Q1 2026.

• Goodwill for Q1 2026 came in at $10.7 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.7 million (changed 0.0% YoY), and the FY2025 annual result was $10.7 million, changed 0.0% from the prior year.
• Goodwill came in at $10.7 million for Q1 2026 at Castle Biosciences, roughly flat from $10.7 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $10.7 million in Q4 2022 to a low of $10.5 million in Q3 2022.
• The 5-year median for Goodwill is $10.7 million (2022), against an average of $10.7 million.
• Peak annual rise in Goodwill reached 2.04% in 2023, while the deepest fall reached 0.0% in 2023.
• Castle Biosciences' Goodwill stood at $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then changed by 0.0% to $10.7 million in 2024, then changed by 0.0% to $10.7 million in 2025, then changed by 0.0% to $10.7 million in 2026.
• The last three Goodwill figures came in at $10.7 million (Q1 2026), $10.7 million (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.